Jeremie Oubda

Jeremie Oubda is a certified medical dosimetrist with extensive experience in the healthcare field, currently holding positions at Vanderbilt University Medical Center Vanderbilt-Ingram Cancer Center and Massachusetts General Hospital since February 2025 and October 2022, respectively. Oubda also serves as a nuclear medicine technologist at Harris Health System since June 2019 and as president of Tegwende Services LLC since December 2017. Additional experience includes recent roles as a certified medical dosimetrist at Kaiser Permanente and Saint Joseph Medical Center, and a medical dosimetrist at Houston Metro Urology. Oubda's background includes military service as a senior medical representative and senior medical specialist in the U.S. Army, where Oubda focused on medical care operations and employee training in first aid. Educational qualifications include a Bachelor of Applied Science in Medical Dosimetry from The University of Texas M.D. Anderson Cancer Center and multiple associate degrees from Houston Community College in nuclear medicine technology and computer tomography.